Contract 75F40122C00146
Georgia Tech Research Corp · Department Of Health And Human Services · September 28, 2022
Georgia Tech Research Corp was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 28, 2022 for $2.01 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 12, 2025.
Contract details
- PIID
- 75F40122C00146
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Silver Spring, MD
- First action
- September 28, 2022
- Latest action
- August 12, 2025
Description
NO-COST EXTENSION FOR IN VITRO ASSESSMENT OF CHEMICAL MIXTURE-INDUCED AIRWAY INFLAMMATION IN HEALTHY AND DISEASED LUNGS.
Modification timeline
-
August 12, 2025Mod P00001 · Other Administrative Action$2.01M
-
September 28, 2022Base awardBAA TOXWP 118/CTP-2022-112800 -EVALUATE AND PROMOTE THE USE OF CELL- AND TISSUE-BASED ASSAYS THAT MORE ACCURATELY REPRESENT HUMAN SUSCEPTIBILITY THAN ANIMAL MODELS TO ADVERSE REACTIONS AND PREDICT THR…$2.01M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122C00146?
Contract 75F40122C00146 is a federal contract awarded to Georgia Tech Research Corp by Department Of Health And Human Services on September 28, 2022 for $2.01 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40122C00146?
Georgia Tech Research Corp won contract 75F40122C00146 from Department Of Health And Human Services.
How much is contract 75F40122C00146 worth?
Contract 75F40122C00146 has obligated $2.01 million to date.